Frequency of MET exon 14 skipping mutations in non-small cell lung cancer according to technical approach in routine diagnosis: results from a real-life cohort of 2,369 patients

BACKGROUND: Mesenchymal epithelial transition receptor (MET) alterations, including MET exon 14 skipping mutation, are oncogenic in non-small cell lung cancer (NSCLC) and may confer sensitivity to targeted therapy. Given the rarity and the diversity of exon 14 skipping mutations, diagnosis may be ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Champagnac, Anne, Bringuier, Pierre-Paul, Barritault, Marc, Isaac, Sylvie, Watkin, Emmanuel, Forest, Fabien, Maury, Jean-Michel, Girard, Nicolas, Brevet, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330338/
https://www.ncbi.nlm.nih.gov/pubmed/32642122
http://dx.doi.org/10.21037/jtd.2020.04.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330338/
https://www.ncbi.nlm.nih.gov/pubmed/32642122
http://dx.doi.org/10.21037/jtd.2020.04.21

Ejemplares similares